Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate with Pegloticase in Uncontrolled Gout
NCT03994731Phase 4Completed
- Sponsor
- Amgen
- Start
- Jun 2019
- Primary completion
- Mar 2021
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegloticase in gout, sponsored by Amgen. Started Jun 2019; status: completed.
02
Drugs
pegloticase
03
Conditions
gout
Beyond the preview
Go deeper on NCT03994731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03994731.